Torthaí cuardaigh - Benboubker, Lotfi
- 1 - 20 toradh as 23 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
Phase II study of bortezomib–dexamethasone alone or with added cyclophosphamide or lenalidomide for sub-optimal response as second-line treatment for patients with multiple myeloma... de réir Dimopoulos, Meletios A., Beksac, Meral, Benboubker, Lotfi, Roddie, Huw, Allietta, Nathalie, Broer, Esther, Couturier, Catherine, Mazier, Marie-Andrée, Angermund, Ralf, Facon, Thierry
Foilsithe / Cruthaithe 2013Téacs -
2
Primary solitary plasmacytoma of the liver – successful treatment with fractionated stereotactic radiotherapy (Cyberknife®): a case report de réir Chalopin, Thomas, Barillot, Isabelle, Biny, Jean-Paul, Arbion, Flavie, Besson, Marie, Santiago-Ribeiro, Maria, Piver, Eric, Herault, Olivier, Gyan, Emmanuel, Benboubker, Lotfi
Foilsithe / Cruthaithe 2017Téacs -
3
Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma de réir Dimopoulos, Meletios A., Orlowski, Robert Z., Facon, Thierry, Sonneveld, Pieter, Anderson, Kenneth C., Beksac, Meral, Benboubker, Lotfi, Roddie, Huw, Potamianou, Anna, Couturier, Catherine, Feng, Huaibao, Ataman, Ozlem, van de Velde, Helgi, Richardson, Paul G.
Foilsithe / Cruthaithe 2015Téacs -
4
Elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma: final phase 2 results from the randomised, open-label, phase 1b–2 dose-esc... de réir Richardson, Paul G, Jagannath, Sundar, Moreau, Philippe, Jakubowiak, Andrzej J, Raab, Marc S, Facon, Thierry, Vij, Ravi, White, Darrell, Reece, Donna E, Benboubker, Lotfi, Zonder, Jeffrey, Tsao, L Claire, Anderson, Kenneth C, Bleickardt, Eric, Singhal, Anil K, Lonial, Sagar
Foilsithe / Cruthaithe 2015Téacs -
5
All-oral triplet combination of ixazomib, lenalidomide, and dexamethasone in newly diagnosed transplant-eligible multiple myeloma patients: final results of the phase II IFM 2013-0... de réir Touzeau, Cyrille, Perrot, Aurore, Roussel, Murielle, Karlin, Lionel, Benboubker, Lotfi, Jacquet, Caroline, Mohty, Mohamad, Facon, Thierry, Manier, Salomon, Chretien, Marie-Lorraine, Tiab, Mourad, Hulin, Cyrille, Leleu, Xavier, Loiseau, Hervé Avet, Dejoie, Thomas, Planche, Lucie, Attal, Michel, Moreau, Philippe
Foilsithe / Cruthaithe 2022Téacs -
6
Daratumumab plus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma de réir Chari, Ajai, Martinez-Lopez, Joaquín, Mateos, María-Victoria, Bladé, Joan, Benboubker, Lotfi, Oriol, Albert, Arnulf, Bertrand, Rodriguez-Otero, Paula, Pineiro, Luis, Jakubowiak, Andrzej, de Boer, Carla, Wang, Jianping, Clemens, Pamela L., Ukropec, Jon, Schecter, Jordan, Lonial, Sagar, Moreau, Philippe
Foilsithe / Cruthaithe 2019Téacs -
7
Subcutaneous delivery of daratumumab in relapsed or refractory multiple myeloma de réir Usmani, Saad Z., Nahi, Hareth, Mateos, Maria-Victoria, van de Donk, Niels W. C. J., Chari, Ajai, Kaufman, Jonathan L., Moreau, Philippe, Oriol, Albert, Plesner, Torben, Benboubker, Lotfi, Hellemans, Peter, Masterson, Tara, Clemens, Pamela L., Luo, Man, Liu, Kevin, San-Miguel, Jesus
Foilsithe / Cruthaithe 2019Téacs -
8
Daratumumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended follow-up of POLLUX, a randomized, open-label, phase 3 study de réir Bahlis, Nizar J., Dimopoulos, Meletios A., White, Darrell J., Benboubker, Lotfi, Cook, Gordon, Leiba, Merav, Ho, P. Joy, Kim, Kihyun, Takezako, Naoki, Moreau, Philippe, Kaufman, Jonathan L., Krevvata, Maria, Chiu, Christopher, Qin, Xiang, Okonkwo, Linda, Trivedi, Sonali, Ukropec, Jon, Qi, Ming, San-Miguel, Jesus
Foilsithe / Cruthaithe 2020Téacs -
9
Subcutaneous daratumumab in patients with relapsed or refractory multiple myeloma: part 2 of the open-label, multicenter, dose-escalation phase Ib study (PAVO) de réir San-Miguel, Jesus, Usmani, Saad Z., Mateos, Maria-Victoria, van de Donk, Niels W.C.J., Kaufman, Jonathan L., Moreau, Philippe, Oriol, Albert, Plesner, Torben, Benboubker, Lotfi, Liu, Kevin, Hellemans, Peter, Masterson, Tara, Clemens, Pamela L., Luo, Man, Farnsworth, Andrew, Nahi, Hareth, Chari, Ajai
Foilsithe / Cruthaithe 2020Téacs -
10
Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age: subgroup analysis of the phase 3 CASTOR and... de réir Mateos, Maria-Victoria, Spencer, Andrew, Nooka, Ajay K., Pour, Ludek, Weisel, Katja, Cavo, Michele, Laubach, Jacob P., Cook, Gordon, Iida, Shinsuke, Benboubker, Lotfi, Usmani, Saad Z., Yoon, Sung-Soo, Bahlis, Nizar J., Chiu, Christopher, Ukropec, Jon, Schecter, Jordan M., Qin, Xiang, O’Rourke, Lisa, Dimopoulos, Meletios A.
Foilsithe / Cruthaithe 2020Téacs -
11
Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy: A Randomized Clinical Trial de réir Bridoux, Frank, Carron, Pierre-Louis, Pegourie, Brigitte, Alamartine, Eric, Augeul-Meunier, Karine, Karras, Alexandre, Joly, Bertrand, Peraldi, Marie-Noëlle, Arnulf, Bertrand, Vigneau, Cécile, Lamy, Thierry, Wynckel, Alain, Kolb, Brigitte, Royer, Bruno, Rabot, Nolwenn, Benboubker, Lotfi, Combe, Christian, Jaccard, Arnaud, Moulin, Bruno, Knebelmann, Bertrand, Chevret, Sylvie, Fermand, Jean-Paul
Foilsithe / Cruthaithe 2017Téacs -
12
Phase I dose-escalation study of F50067, a humanized anti-CXCR4 monoclonal antibody alone and in combination with lenalidomide and low-dose dexamethasone, in relapsed or refractory... de réir Fouquet, Guillemette, Guidez, Stéphanie, Richez, Valentine, Stoppa, Anne-Marie, Le Tourneau, Christophe, Macro, Margaret, Gruchet, Cécile, Bobin, Arthur, Moya, Niels, Syshenko, Thomas, Sabirou, Florence, Levy, Anthony, Franques, Paul, Gardeney, Hélène, Karlin, Lionel, Benboubker, Lotfi, Ouali, Monia, Vedovato, Jean-Claude, Ferre, Pierre, Pavlyuk, Mariya, Attal, Michel, Facon, Thierry, Leleu, Xavier
Foilsithe / Cruthaithe 2018Téacs -
13
Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma de réir Facon, Thierry, Venner, Christopher P., Bahlis, Nizar J., Offner, Fritz, White, Darrell J., Karlin, Lionel, Benboubker, Lotfi, Rigaudeau, Sophie, Rodon, Philippe, Voog, Eric, Yoon, Sung-Soo, Suzuki, Kenshi, Shibayama, Hirohiko, Zhang, Xiaoquan, Twumasi-Ankrah, Philip, Yung, Godwin, Rifkin, Robert M., Moreau, Philippe, Lonial, Sagar, Kumar, Shaji K., Richardson, Paul G., Rajkumar, S. Vincent
Foilsithe / Cruthaithe 2021Téacs -
14
Stem cell yield and transplantation in transplant-eligible newly diagnosed multiple myeloma patients receiving daratumumab plus bortezomib/thalidomide/dexamethasone in the phase II... de réir Hulin, Cyrille, Offner, Fritz, Moreau, Philippe, Roussel, Murielle, Belhadj, Karim, Benboubker, Lotfi, Caillot, Denis, Facon, Thierry, Garderet, Laurent, Kuhnowski, Frédérique, Stoppa, Anne-Marie, Kolb, Brigitte, Tiab, Mourad, Jie, Kon-Siong, Westerman, Matthijs, Lambert, Jérôme, Pei, Lixia, Vanquickelberghe, Veronique, de Boer, Carla, Vermeulen, Jessica, Kampfenkel, Tobias, Sonneveld, Pieter, van de Donk, Niels W.C.J.
Foilsithe / Cruthaithe 2021Téacs -
15
Combination of International Scoring System 3, High Lactate Dehydrogenase, and t(4;14) and/or del(17p) Identifies Patients With Multiple Myeloma (MM) Treated With Front-Line Autolo... de réir Moreau, Philippe, Cavo, Michele, Sonneveld, Pieter, Rosinol, Laura, Attal, Michel, Pezzi, Annalisa, Goldschmidt, Hartmut, Lahuerta, Juan Jose, Marit, Gerald, Palumbo, Antonio, van der Holt, Bronno, Bladé, Joan, Petrucci, Maria Teresa, Neben, Kai, san Miguel, Jesus, Patriarca, Francesca, Lokhorst, Henk, Zamagni, Elena, Hulin, Cyrille, Gutierrez, Norma, Facon, Thierry, Caillot, Denis, Benboubker, Lotfi, Harousseau, Jean-Luc, Leleu, Xavier, Avet-Loiseau, Hervé, Mary, Jean-Yves
Foilsithe / Cruthaithe 2014Téacs -
16
Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA de réir Facon, Thierry, Cook, Gordon, Usmani, Saad Z., Hulin, Cyrille, Kumar, Shaji, Plesner, Torben, Touzeau, Cyrille, Bahlis, Nizar J., Basu, Supratik, Nahi, Hareth, Goldschmidt, Hartmut, Quach, Hang, Mohty, Mohamad, Venner, Christopher P., Weisel, Katja, Raje, Noopur, Hebraud, Benjamin, Belhadj-Merzoug, Karim, Benboubker, Lotfi, Decaux, Olivier, Manier, Salomon, Caillot, Denis, Ukropec, Jon, Pei, Huiling, Van Rampelbergh, Rian, Uhlar, Clarissa M., Kobos, Rachel, Zweegman, Sonja
Foilsithe / Cruthaithe 2022Téacs -
17
Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 tri... de réir Rodon, Philippe, Hulin, Cyrille, Pegourie, Brigitte, Tiab, Mourad, Anglaret, Bruno, Benboubker, Lotfi, Jardel, Henry, Decaux, Olivier, Kolb, Brigitte, Roussel, Murielle, Garderet, Laurent, Leleu, Xavier, Fitoussi, Olivier, Chaleteix, Carine, Casassus, Philippe, Lenain, Pascal, Royer, Bruno, Banos, Anne, Benramdane, Riad, Cony-Makhoul, Pascale, Dib, Mamoun, Fontan, Jean, Stoppa, Anne-Marie, Traullé, Catherine, Vilque, Jean-Pierre, Pétillon, Marie-Odile, Mathiot, Claire, Dejoie, Thomas, Avet-Loiseau, Hervé, Moreau, Philippe
Foilsithe / Cruthaithe 2015Téacs -
18
Prospective Evaluation of Magnetic Resonance Imaging and [(18)F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in S... de réir Moreau, Philippe, Attal, Michel, Caillot, Denis, Macro, Margaret, Karlin, Lionel, Garderet, Laurent, Facon, Thierry, Benboubker, Lotfi, Escoffre-Barbe, Martine, Stoppa, Anne-Marie, Laribi, Kamel, Hulin, Cyrille, Perrot, Aurore, Marit, Gerald, Eveillard, Jean-Richard, Caillon, Florence, Bodet-Milin, Caroline, Pegourie, Brigitte, Dorvaux, Veronique, Chaleteix, Carine, Anderson, Kenneth, Richardson, Paul, Munshi, Nikhil C., Avet-Loiseau, Herve, Gaultier, Aurelie, Nguyen, Jean-Michel, Dupas, Benoit, Frampas, Eric, Kraeber-Bodere, Françoise
Foilsithe / Cruthaithe 2017Téacs -
19
Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX de réir Kaufman, Jonathan L., Dimopoulos, Meletios A., White, Darrell, Benboubker, Lotfi, Cook, Gordon, Leiba, Merav, Morton, James, Joy Ho, P., Kim, Kihyun, Takezako, Naoki, Moreau, Philippe, Sutherland, Heather J., Magen, Hila, Iida, Shinsuke, Kim, Jin Seok, Miles Prince, H., Cochrane, Tara, Oriol, Albert, Bahlis, Nizar J., Chari, Ajai, O’Rourke, Lisa, Trivedi, Sonali, Casneuf, Tineke, Krevvata, Maria, Ukropec, Jon, Kobos, Rachel, Avet-Loiseau, Hervé, Usmani, Saad Z., San-Miguel, Jesus
Foilsithe / Cruthaithe 2020Téacs -
20
Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX de réir Dimopoulos, Meletios A., San-Miguel, Jesus, Belch, Andrew, White, Darrell, Benboubker, Lotfi, Cook, Gordon, Leiba, Merav, Morton, James, Ho, P. Joy, Kim, Kihyun, Takezako, Naoki, Moreau, Philippe, Kaufman, Jonathan L., Sutherland, Heather J., Lalancette, Marc, Magen, Hila, Iida, Shinsuke, Kim, Jin Seok, Prince, H. Miles, Cochrane, Tara, Oriol, Albert, Bahlis, Nizar J., Chari, Ajai, O’Rourke, Lisa, Wu, Kaida, Schecter, Jordan M., Casneuf, Tineke, Chiu, Christopher, Soong, David, Sasser, A. Kate, Khokhar, Nushmia Z., Avet-Loisea, Hervé, Usmani, Saad Z.
Foilsithe / Cruthaithe 2018Téacs